NCT01672970View on ClinicalTrials.gov

A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

291

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Rheumatoid Arthritis
Trial Locations (20)

1023

Budapest

1027

Budapest

1062

Budapest

2143

Kistarcsa

2500

Esztergom

3300

Eger

3529

Miskolc

4032

Debrecen

4043

Debrecen

4400

Nyíregyháza

5000

Szolnok

5700

Gyula

6000

Kecskemét

6724

Szeged

7632

Pécs

8000

Székesfehérvár

8200

Veszprém

8380

Hévíz

9004

Győr

9700

Szombathely

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01672970 - A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter